Cargando…
Tolvaptan, Kidney Function Decline, and Potential Confounding by Muscle Wasting
Autores principales: | Groothof, Dion, Post, Adrian, Bakker, Stephan J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577130/ https://www.ncbi.nlm.nih.gov/pubmed/37850076 http://dx.doi.org/10.1016/j.xkme.2023.100711 |
Ejemplares similares
-
Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
por: Post, Adrian, et al.
Publicado: (2020) -
Muscle mass versus body mass index as predictor of adverse outcome
por: Groothof, Dion, et al.
Publicado: (2021) -
Plasma Thallium Concentration, Kidney Function, Nephrotoxicity and Graft Failure in Kidney Transplant Recipients
por: Kremer, Daan, et al.
Publicado: (2022) -
Dietary lithium intake, graft failure and mortality in kidney transplant recipients
por: Post, Adrian, et al.
Publicado: (2022) -
Confounding by linkage disequilibrium
por: Aissani, Brahim
Publicado: (2014)